Literature DB >> 28237949

Over 10 years MRI observation of a patient with neuronal intranuclear inclusion disease.

Kazuo Abe1, Masashi Fujita2.   

Abstract

We present a sporadic neuronal intranuclear inclusion disease (NIID) patient with neuropathy followed by cognitive dysfunction along with brain MRIs findings of leucoencephalopathy. Her cognitive impairment gradually progressed along with abnormal intensity lesions in diffusion-weighted images. This pathological and clinical deterioration resemble pathological process in prion diseases. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28237949      PMCID: PMC5337643          DOI: 10.1136/bcr-2016-218790

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


Background

Neuronal intranuclear inclusion disease (NIID) is a progressive neurodegenerative disease characterised by eosinophilic hyaline intranuclear inclusions, which are widely observed in neuronal and somatic cells.1–6 NIID has been considered to be a heterogeneous disease with highly variable clinical manifestations such as neuropathy, cerebellar ataxia and dementia, which may occur concomitantly in certain patients. Sporadic and familial patients have been reported, and the onset of disease varies from the infantile stages to late middle age. These factors made the ante mortem diagnosis of NIID difficult, but Sonoe et al5 6 reported possible usefulness of skin or muscle biopsy and suggested a possible antemortem diagnostic biomarker for NIID. However, longitudinal observation of characteristic leucoencephalopathy in NIID has never been reported. In this study, we present a sporadic NIID patient with neuropathy followed by cognitive dysfunction along with brain MRIs findings of leucoencephalopathy.

Case presentation

A 62-year-old woman noticed jingling sensation bilaterally in the feet since she was 52 years old and consulted to our clinic. On the neurological examination, she had sensory disturbances bilaterally in the feet, but her deep tendon reflexes were normal. She had normal findings including her cognitive function. She showed 30 out of 30 in the total scores of mini-mental state examination (MMSE). She showed relatively prolonged sensory nerve conductive velocities (NCVs) (30 m/sec) in the median nerves, ulnar nerves and anterior tibial nerves, but had normal motor NCVs in those nerves. The results of NCVs supported that she had neuropathy. On the MRIs, she showed ischaemic lesions in the white matter in the T2-weighted images (TWIs), high-intensity lesion in the corpus callosum in the fluid attenuated inversion recovery (FLAIR) images (figure 1).
Figure 1

Brain MRI findings. Brain MRI findings showed leucoencephalopathy in T2-weighted and fluid attenuation recovery (FLAIR) images, and showed high-intensity lesions in the corpus callosum. On diffusion-weighted images (DWIs), high intensities were observed from the corticomedullary junction to around the root of gyrus. These abnormal MRI findings were gradually expanded from the frontal to the occipital that were more prominent in DWIs.

Brain MRI findings. Brain MRI findings showed leucoencephalopathy in T2-weighted and fluid attenuation recovery (FLAIR) images, and showed high-intensity lesions in the corpus callosum. On diffusion-weighted images (DWIs), high intensities were observed from the corticomedullary junction to around the root of gyrus. These abnormal MRI findings were gradually expanded from the frontal to the occipital that were more prominent in DWIs. During 3 years from the first admission, she gradually developed attention deficits and forgetfulness. At that time, she showed 27 out of 30 in the total scores of MMSE. On the MRIs, in addition to findings in the first admission, she showed high-intensity lines along with U-fibres in diffusion-weighted images (DWIs). In the consecutive MRIs, these findings in the MRIs gradually worsened (figure 1). However, at 10 years after the first admission, her neuropathy remained as the level of the first admission. She had attention deficits and forgetfulness and showed 26 out of 30 in the total scores of MMSE.

Outcome and follow-up

We followed her in this time.

Discussion

We reported a patient of leucoencephalopathy with NIID who presented with cognitive dysfunction. The high intensity of the U-fibres in the DWIs is a characteristic finding in NIID that imply existence of intranuclear inclusions in the cerebral cortex. The parallel MRI changes in the DWIs along with cognitive decline supports those U-fibres changes in the DWIs play a pathogenic role in NIID. Sone et al7 recently reported clinicopathological features of NIID, and in that sporadic patients developed initially dementia followed by sensory disturbances, ataxia. Our patient has no family history and developed sensory disturbances followed by dementia. Her sensory disturbances remain rather unchanged, but cognitive impairment gradually progressed along with abnormal intensity lesions in DWIs. Her initial symptom was forgetfulness and inattention. Her total scores in MMSE deteriorated from 30 to 26 and those of frontal assessment battery from 18 to 16 due to verbal influency. This pathological and clinical deterioration resemble pathological process in prion diseases that implies similar pathological processes affected in NIID. Recently, on the basis of neuropathological studies, Masuda-Suzukake M et al8 indicated that α-synuclein fibrils have prion-like properties9 and inoculation into wild-type brain induces α-synuclein pathology in vivo. Accumulation of consecutive MRI observation in NIID patients may be useful to elucidate the mechanism of pathological processes affected in NIID. This is the first report to follow MRIs changes for over long period. Neuronal intranuclear inclusion disease (NIID) is a progressive neurodegenerative disease characterised by eosinophilic hyaline intranuclear inclusions. MRI observation in NIID patients may be useful. Prion-like properties.
  9 in total

Review 1.  Neuronal intranuclear hyaline inclusion disease.

Authors:  Junko Takahashi-Fujigasaki
Journal:  Neuropathology       Date:  2003-12       Impact factor: 1.906

2.  Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy.

Authors:  Jun Sone; Naoyuki Kitagawa; Eriko Sugawara; Masaaki Iguchi; Ryoichi Nakamura; Haruki Koike; Yasushi Iwasaki; Mari Yoshida; Tatsuya Takahashi; Susumu Chiba; Masahisa Katsuno; Fumiaki Tanaka; Gen Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-09-13       Impact factor: 10.154

3.  A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection.

Authors:  R Lindenberg; L J Rubinstein; M M Herman; G B Haydon
Journal:  Acta Neuropathol       Date:  1968-01-02       Impact factor: 17.088

4.  Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.

Authors:  J Sone; F Tanaka; H Koike; A Inukai; M Katsuno; M Yoshida; H Watanabe; G Sobue
Journal:  Neurology       Date:  2011-03-16       Impact factor: 9.910

Review 5.  Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.

Authors:  J M Woulfe
Journal:  Neuropathol Appl Neurobiol       Date:  2007-02       Impact factor: 8.090

Review 6.  Genetic and infectious prion diseases.

Authors:  S B Prusiner
Journal:  Arch Neurol       Date:  1993-11

7.  An unusual degenerative disorder of neurons associated with a novel intranuclear hyaline inclusion (neuronal intranuclear hyaline inclusion disease). A clinicopathological study of a case.

Authors:  J H Sung; M Ramirez-Lassepas; A R Mastri; S M Larkin
Journal:  J Neuropathol Exp Neurol       Date:  1980-03       Impact factor: 3.685

8.  Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.

Authors:  Jun Sone; Keiko Mori; Tomonori Inagaki; Ryu Katsumata; Shinnosuke Takagi; Satoshi Yokoi; Kunihiko Araki; Toshiyasu Kato; Tomohiko Nakamura; Haruki Koike; Hiroshi Takashima; Akihiro Hashiguchi; Yutaka Kohno; Takashi Kurashige; Masaru Kuriyama; Yoshihisa Takiyama; Mai Tsuchiya; Naoyuki Kitagawa; Michi Kawamoto; Hajime Yoshimura; Yutaka Suto; Hiroyuki Nakayasu; Naoko Uehara; Hiroshi Sugiyama; Makoto Takahashi; Norito Kokubun; Takuya Konno; Masahisa Katsuno; Fumiaki Tanaka; Yasushi Iwasaki; Mari Yoshida; Gen Sobue
Journal:  Brain       Date:  2016-10-25       Impact factor: 13.501

9.  Prion-like spreading of pathological α-synuclein in brain.

Authors:  Masami Masuda-Suzukake; Takashi Nonaka; Masato Hosokawa; Takayuki Oikawa; Tetsuaki Arai; Haruhiko Akiyama; David M A Mann; Masato Hasegawa
Journal:  Brain       Date:  2013-03-06       Impact factor: 13.501

  9 in total
  7 in total

1.  Identifying patients with neuronal intranuclear inclusion disease in Singapore using characteristic diffusion-weighted MR images.

Authors:  Wai-Yung Yu; Zheyu Xu; Hwei-Yee Lee; Aya Tokumaru; Jeanne M M Tan; Adeline Ng; Shigeo Murayama; C C Tchoyoson Lim
Journal:  Neuroradiology       Date:  2019-07-11       Impact factor: 2.804

Review 2.  Enabling biodegradable functional biomaterials for the management of neurological disorders.

Authors:  Dingying Shan; Chuying Ma; Jian Yang
Journal:  Adv Drug Deliv Rev       Date:  2019-06-20       Impact factor: 15.470

3.  Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders.

Authors:  Yun Tian; Jun-Ling Wang; Wen Huang; Sheng Zeng; Bin Jiao; Zhen Liu; Zhao Chen; Yujing Li; Ying Wang; Hao-Xuan Min; Xue-Jing Wang; Yong You; Ru-Xu Zhang; Xiao-Yu Chen; Fang Yi; Ya-Fang Zhou; Hong-Yu Long; Chao-Jun Zhou; Xuan Hou; Jun-Pu Wang; Bin Xie; Fan Liang; Zhuan-Yi Yang; Qi-Ying Sun; Emily G Allen; Andrew Mark Shafik; Ha Eun Kong; Ji-Feng Guo; Xin-Xiang Yan; Zheng-Mao Hu; Kun Xia; Hong Jiang; Hong-Wei Xu; Ran-Hui Duan; Peng Jin; Bei-Sha Tang; Lu Shen
Journal:  Am J Hum Genet       Date:  2019-06-06       Impact factor: 11.025

4.  Adult-onset neuronal intranuclear inclusion disease presenting with typical MRI changes.

Authors:  Xinsheng Han; Miao Han; Ning Liu; Jianke Xu; Yan Zhang; Yun Zhang; Daojun Hong; Wei Zhang
Journal:  Brain Behav       Date:  2019-11-20       Impact factor: 2.708

5.  Adult-onset neuronal intranuclear inclusion disease, with both stroke-like onset and encephalitic attacks: a case report.

Authors:  Ying Huang; Ge Jin; Qun-Ling Zhan; Yun Tian; Lu Shen
Journal:  BMC Neurol       Date:  2021-03-31       Impact factor: 2.474

6.  Sporadic adult-onset neuronal intranuclear inclusion disease without high-intensity signal on DWI and T2WI: a case report.

Authors:  Hongfen Wang; Feng Feng; Jiajin Liu; Jianwen Deng; Jiongming Bai; Wei Zhang; Luning Wang; Baixuan Xu; Xusheng Huang
Journal:  BMC Neurol       Date:  2022-04-22       Impact factor: 2.903

Review 7.  Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Authors:  Yueqi Liu; Hao Li; Xuan Liu; Bin Wang; Hao Yang; Bo Wan; Miao Sun; Xingshun Xu
Journal:  Front Aging Neurosci       Date:  2022-09-13       Impact factor: 5.702

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.